● Recruiting

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

Condition: Cardiovascular Disease · Sponsor: Amgen

PhasePhase 3

Planned participants11000

Who can joinAll sexes, 50 Years to 105 Years

Healthy volunteersNo

About this study

The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardial infarction, or urgent coronary revascularization in participants at risk for a first major cardiovascular event with elevated lipoprotein(a) (Lp\[a\]).

This description comes directly from the study's public registry record.

Talk to the study team

Amgen Call Center · 866-572-6436 · medinfo@amgen.com

Always discuss trial participation with your own doctor first.

Locations (249)

Advanced Cardiovascular LLC	Alexander City, Alabama, United States	Recruiting
University of Alabama Birmingham Saint Vincents Birmingham	Birmingham, Alabama, United States	Recruiting
Birmingham Clinical Research	Birmingham, Alabama, United States	Recruiting
Alliance For Multispecialty Research - Daphne	Daphne, Alabama, United States	Recruiting
Eastern Shore Research Institute	Fairhope, Alabama, United States	Recruiting
Heart Center Research LLC	Huntsville, Alabama, United States	Recruiting
CB Flock Research Corporation	Mobile, Alabama, United States	Recruiting
Phoenix Clinical	Phoenix, Arizona, United States	Recruiting
Elite Clinical Studies LLC	Phoenix, Arizona, United States	Recruiting
Hero Clinical Research	Phoenix, Arizona, United States	Recruiting
HonorHealth Research Institute	Scottsdale, Arizona, United States	Recruiting
Eclipse Clinical Research	Tucson, Arizona, United States	Recruiting

+ 237 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07136012